85 related articles for article (PubMed ID: 25190221)
1. Association study of miR‑149 rs2292832 and miR‑608 rs4919510 and the risk of hepatocellular carcinoma in a large‑scale population.
Wang R; Zhang J; Ma Y; Chen L; Guo S; Zhang X; Ma Y; Wu L; Pei X; Liu S; Wang J; Hu H; Liu J
Mol Med Rep; 2014 Nov; 10(5):2736-44. PubMed ID: 25190221
[TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
3. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
4. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
5. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
7. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population.
Farokhizadeh Z; Dehbidi S; Geramizadeh B; Yaghobi R; Malekhosseini SA; Behmanesh M; Sanati MH; Afshari A; Moravej A; Karimi MH
Ann Lab Med; 2019 Jan; 39(1):58-66. PubMed ID: 30215231
[TBL] [Abstract][Full Text] [Related]
8. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
9. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population.
Al-Qahtani AA; Al-Anazi MR; Nazir N; Wani K; Abdo AA; Sanai FM; Khan MQ; Al-Ashgar HI; Albenmousa A; Al-Hamoudi WK; Alswat KA; Al-Ahdal MN
J Viral Hepat; 2017 Dec; 24(12):1132-1142. PubMed ID: 28685993
[TBL] [Abstract][Full Text] [Related]
11. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B.
Riazalhosseini B; Mohamed Z; Apalasamy YD; Eng HS; Mohamed R
Pharmacogenet Genomics; 2016 Feb; 26(2):74-9. PubMed ID: 26529280
[TBL] [Abstract][Full Text] [Related]
12. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.
Wang XH; Wang FR; Tang YF; Zou HZ; Zhao YQ
Genet Mol Res; 2014 Jul; 13(3):5048-54. PubMed ID: 25061729
[TBL] [Abstract][Full Text] [Related]
13. Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.
Xie HY; Xing CY; Wei BJ; Xu X; Wu J; Chen LM; Cao GQ; Chen H; Chen KJ; Yin SY; Wu LM; Zhou L; Zheng SS
Tissue Antigens; 2014 Sep; 84(3):264-70. PubMed ID: 24758241
[TBL] [Abstract][Full Text] [Related]
14. TXNDC5 gene polymorphism contributes to increased risk of hepatocellular carcinoma in the Korean male population.
Park MS; Kim SK; Shin HP; Lee SM; Chung JH
Anticancer Res; 2013 Sep; 33(9):3983-7. PubMed ID: 24023338
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
18. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
20. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.
Nan YL; Hu YL; Liu ZK; Duan FF; Xu Y; Li S; Li T; Chen DF; Zeng XY
World J Gastroenterol; 2016 Jun; 22(24):5558-67. PubMed ID: 27350734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
